Med Surg Test 2

Front 1

PRESSURE ULCER

Back 1

A LOCALIZED AREA OF TISSUE NECROSIS CAUSED BY UNRELIEVED PRESSURE THAT OCCLUDES BLOOD FLOW TO THE TISSUES

Front 2

MOST COMMON SITE FOR PRESSURE ULCERS

Back 2

THE SACRUM

Front 3

FACTORS THAT INFLUENCE THE DEVELOPMENT OF PRESSURE ULCERS

Back 3

-INTENSITY
-DURATION
-ABILITY OF THE PT'S TISSUE TO TOLERATE THE PRESSURE APPLIED

Front 4

STAGE 1 PRESSURE ULCERS

Back 4

SKIN INTACT
REDNESS, PAIN, ITCHING
FIRM OR BOGGY FEEL
WARMTH OR COOLNESS

Front 5

STAGE 2 PRESSURE ULCERS

Back 5

PARTIAL-THICKNESS SKIN LOSS INVOLVING EPIDERMIS, DERMIS, OR BOTH. THE ULCER IS SUPERFICIAL AND PRESENTS AS AN ABRASION, BLISTER, OR SHALLOW CRATER

Front 6

STAGE 3 PRESSURE ULCER

Back 6

FULL-THICKNESS SKIN LOSS INVOLVING DAMAGE TO, OR NERCROSIS OF, SUB Q TISSUE THAT MAYEXTEND DOWN TO, BUT NOT THROUGH, UNDERLYING FASCIA. ULCER PRESENTS AS A DEEP CRATER WITH OR WITHOUT UNDERMINING OF ADJACENT TISSUE

Front 7

STAGE 4 PRESSURE ULCER

Back 7

FULL-THICKNESS SKIN LOSS WITH EXTENSIVE DESTRUCTION, TISSUE NECROSIS, OR DAMAGE TO MUSCLE, BONE, OR SUPPORTING STRUCTURES. UNDERMINING AND SINUS TRACTS MAY ALSO BE ASSOCIATED WITH STAGE 4 PU

Front 8

DEHISCENCE

Back 8

THE SEPARATION AND DISRUPTION OF PREVIOUSLY JOINED WOUNDS

Front 9

3 CONTIBUTING FACTORS TO DEHISCENCE

Back 9

-INFECTION MAY CAUSE INFLAMMATION
-THE GRANULATION MAY NOT BE STRONG ENOUGH TO WITHSTAND THE FORCES IMPOSED ON THE WOUND
-OBESE PT'S ARE AT A HIGH RISK B/C ADIPOSE TISSUE INTERFERES WITH HEALING

Front 10

EVISCERATION

Back 10

WHEN WOUND EDGES SEPARATE TO TE EXTENT THAT INTESTINES PROTUDE THROUGH THE WOUND

Front 11

GUAZES AND NONWOVENS

Back 11

PROVIDES ABSORPTION OF EXUDATES. CAN BE USED FOR CLEANSING, PACKING, AND COVERING A VARIETY OF WOUNDS

Front 12

NONADHERENT DRESSINGS

Back 12

MINIMALLY ABSORBENT
USED MAINLY ON MINOR WOUNDS OR AS A SECOND
DRESSING
EX. ADAPTIC, VASELINE GAUZE, XEROFOAM

Front 13

TRASPARENT FILMS

Back 13

SEMIPERMEABLE MEMBRAE THAT PERMITS GASEOUS EXCHANGE BETWEEN WOUND AND ENVIRONMENT. USED FOR DRY NONINFECTED WOUNDS OR WOUNDS WITH MINIMAL DRAINAGE.
EX. BIOCLUSIVE, TEGADERM

Front 14

HYDROCOLLOIDS

Back 14

WAFERS, POWDERS, OR PASTES COMPOSED OF GELATIN, PECTIN. DRESSING DOSE NOT ALLOW O2 TO DIFFUSE FROM ATOMOSPHERE TO WOUND. SUPPORTS DEBRIDEMENT AND PREVENTS SECONDARY INFECTIONS. USED FOR SUPERFICIALAND PARTIAL-THICKNESS WOUNDS W/LIGHT TO MODERATE DRAINAGE

Front 15

FOAMS

Back 15

SHEETS AND OTHER SHAPES OF FOAMED POLYMER SOLUTIONS WITH SMALL, OPEN CELLS CAPABLEOF HOLDING FLUIDS. MODERATE TO HEAVY AMOUNTS CAN BE ABSORBED. USED FOR PARTIAL- OR FULL-THICKNESS WOUNDS OR INFECTED WOUNDS. EX-ALLEVYN, CURAFOAM, FLEXZAN, POLYDERM

Front 16

absorptive dressings

Back 16

large volumes can be absorbed. moist wound surface. for partial/full-thickness or infected wounds. ex. ABD combine pads, covaderm, multipad.

Front 17

hydrogel

Back 17

available as sheet, gel and gauzedesigned to donate moisture to a dry wound to maintain a moist healing envirnoment. used for deep wounds w/minimal drainage and necrotic wounds. ex. aquasite, curasol gel, hypergel, tegagel

Front 18

alginates

Back 18

nonwoven, nonadhesive pads and ribbons composed of natural polysaccharide fibers and xerogel derived from seaweed. for wounds with moderate to heavy excudates (pressure wounds, infected wounds) ex algicell, algisite, seasorb

Front 19

antimicrobials

Back 19

deliver agent such that have antibacterial properties. partial and full thickness wounds. surgical incisions, around tracheostomies. ex. acticoat, BIOPATCH, curity AMD, silverderm

Front 20

clinical signs of infection

Back 20

purulent exudate, odor, erythema, warmth, tenderness, edema, pain, fever, and elevated WBC count

Front 21

preoperative assessment of a patient

Back 21

overall goal to gather data in order to identify risk factors and plan care to ensure patient safetly throughout the surgical experience.